IL-22 is well-known for its hepatoprotective (131), pro-regenerative (132), and antimicrobial abilities (133), while ACLF is associated with hepatocyte damage, impaired liver regeneration, and bacterial infection; therefore, IL-22 treatment could benefit the problems that arise in ACLF. The gene discussed is IL22; the disease is bacterial infectious disease.